Yuyu Pharma, Inc. (KRX:000225)

South Korea · Delayed Price · Currency is KRW

3,265.00

-30.00 (-0.91%)

Nov 4, 2026, 3:30 PM KST

Market Cap	58.42B -9.4%
Revenue (ttm)	144.37B +6.7%
Net Income	12.18B +145.4%
EPS	694.87 +150.9%
Shares Out	n/a
PE Ratio	4.70
Forward PE	n/a
Dividend	125.00 (3.83%)
Ex-Dividend Date	Dec 29, 2025

Volume	4,714
Open	3,280.00
Previous Close	3,295.00
Day's Range	3,240.00 - 3,280.00
52-Week Range	3,215.00 - 5,700.00
Beta	0.39
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Yuyu Pharma

Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1941

Employees 243

Stock Exchange Korea Stock Exchange

Ticker Symbol 000225

Financial Performance

In 2025, Yuyu Pharma's revenue was 140.88 billion, an increase of 5.81% compared to the previous year's 133.15 billion. Earnings were 7.83 billion, a decrease of -6.89%.

Financial Statements